70 related articles for article (PubMed ID: 26953222)
21. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
Pyo JS; Cho WJ
Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
[TBL] [Abstract][Full Text] [Related]
22. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
[TBL] [Abstract][Full Text] [Related]
23. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
24. The Expression of Inflammatory Mediators in Bladder Pain Syndrome.
Offiah I; Didangelos A; Dawes J; Cartwright R; Khullar V; Bradbury EJ; O'Sullivan S; Williams D; Chessell IP; Pallas K; Graham G; O'Reilly BA; McMahon SB
Eur Urol; 2016 Aug; 70(2):283-90. PubMed ID: 26965559
[TBL] [Abstract][Full Text] [Related]
25. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.
Lazzeri M; Hurle R; Casale P; Buffi N; Lughezzani G; Fiorini G; Peschechera R; Pasini L; Zandegiacomo S; Benetti A; Taverna G; Guazzoni G; Barbagli G
Ther Adv Urol; 2016 Apr; 8(2):91-9. PubMed ID: 27034722
[TBL] [Abstract][Full Text] [Related]
26. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.
Janicki JJ; Chancellor MB; Kaufman J; Gruber MA; Chancellor DD
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999210
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Adding Dutasteride to α-Blocker Therapy Treated Benign Prostatic Hyperplasia Patients with Small Volume Prostate (<30 mL).
Hashimoto M; Shimizu N; Sugimoto K; Hongoh S; Minami T; Nozawa M; Yoshimura K; Hirayama A; Tahara H; Uemura H
Low Urin Tract Symptoms; 2017 Sep; 9(3):157-160. PubMed ID: 26991643
[TBL] [Abstract][Full Text] [Related]
28. Clinical Effect of Switching from a Luteinizing Hormone-Releasing Hormone Agonist to an Antagonist in Patients with Castration-Resistant Prostate Cancer and Serum Testosterone Level ≥ 20 ng/dl.
Soga N; Kageyama T; Ogura Y; Yamada T; Hayashi N
Curr Urol; 2016 Feb; 9(1):31-5. PubMed ID: 26989369
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective.
Angulo JC; Sánchez-Ballester F; Peral C; Rejas J; Ramos J; Snedecor SJ; Sudharshan L; Liu S; Luo X
Actas Urol Esp; 2016 Oct; 40(8):513-22. PubMed ID: 26988624
[TBL] [Abstract][Full Text] [Related]
30. Glycosaminoglycan Replacement Therapy with Intravesical Instillations of Combined Hyaluronic Acid and Chondroitin Sulfate in Patients with Recurrent Cystitis, Post-radiation Cystitis and Bladder Pain Syndrome: A Narrative Review.
Poletajew S; Brzózka MM; Krajewski W; Kamecki H; Nyk Ł; Kryst P
Pain Ther; 2024 Feb; 13(1):1-22. PubMed ID: 37917298
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels
Nicosia L; Vitale C; Cuccia F; Figlia V; Giaj-Levra N; Mazzola R; Ricchetti F; Rigo M; Ruggieri R; Cavalleri S; Alongi F
Cancer Manag Res; 2022; 14():2839-2846. PubMed ID: 36164468
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of mesalazine polymeric conjugate in the treatment of actinic proctitis in rats.
Nunes VRT; Vidigal PVT; Pereira MT; Ladeira LCD; Caliari MV; Oliveira FMS; Cesar ALA; Faraco AAG; Barbuto RC; Duval-Araujo I
Acta Cir Bras; 2021; 36(8):e360805. PubMed ID: 34644773
[TBL] [Abstract][Full Text] [Related]
33. Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies.
Sanguedolce F; Sancho Pardo G; Mercadé Sanchez A; Balaña Lucena J; Pisano F; Cortez JC; Territo A; Huguet Perez J; Gaya Sopeña J; Esquina Lopez C; Breda A; Palou Redorta J
Prostate Int; 2021 Mar; 9(1):48-53. PubMed ID: 33912514
[TBL] [Abstract][Full Text] [Related]
34. Urologic, lymphedema, pelvic pain and gastrointestinal symptoms increase after radiotherapy in patients with primary uterine tumors: a prospective longitudinal Swedish cohort study.
Holmqvist A; Axelsson A; Mikivier R; Redelius K; Odelram Wiréen U; Uppugunduri S
Clin Transl Oncol; 2021 Sep; 23(9):1752-1760. PubMed ID: 33686481
[TBL] [Abstract][Full Text] [Related]
35. Virtual measurements of paracellular permeability and chronic inflammation via color coded pixel-wise T
Singh N; Zabbarova I; Ikeda Y; Maranchie J; Chermansky C; Foley L; Hitchens TK; Yoshimura N; Kanai A; Kaufman J; Tyagi P
Am J Physiol Renal Physiol; 2020 Sep; 319(3):F506-F514. PubMed ID: 32715761
[TBL] [Abstract][Full Text] [Related]
36. Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis.
Goucher G; Saad F; Lukka H; Kapoor A
Can Urol Assoc J; 2019 Feb; 13(2):15-23. PubMed ID: 30721124
[No Abstract] [Full Text] [Related]
37. Gold nanoparticles approach to detect chondroitin sulphate and hyaluronic acid urothelial coating.
Guelfi G; Stefanetti V; Zampini D; Oommen OP; Brecchia G; Dall'Aglio C; Arcelli R; Cochetti G; Boni A; Mearini E
Sci Rep; 2017 Sep; 7(1):10355. PubMed ID: 28871206
[TBL] [Abstract][Full Text] [Related]
38. Modeling of chronic radiation-induced cystitis in mice.
Zwaans BM; Krueger S; Bartolone SN; Chancellor MB; Marples B; Lamb LE
Adv Radiat Oncol; 2016; 1(4):333-343. PubMed ID: 28217761
[TBL] [Abstract][Full Text] [Related]
39. Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study.
Gacci M; Saleh O; Giannessi C; Chini T; Della Camera PA; Detti B; Livi L; Finazzi Agro E; Li Marzi V; Minervini A; Carini M; Oelke M; Gravas S; Serni S
Clin Genitourin Cancer; 2016 Oct; 14(5):444-449. PubMed ID: 26953222
[TBL] [Abstract][Full Text] [Related]
40. Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study.
Gacci M; Saleh O; Giannessi C; Detti B; Livi L; Monteleone Pasquetti E; Masoni T; Finazzi Agro E; Li Marzi V; Minervini A; Carini M; Gravas S; Oelke M; Serni S
BMC Urol; 2015 Jul; 15():65. PubMed ID: 26148853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
